Hudson Bay Capital Management
Overview
Hudson Bay Capital Management is a multi-strategy investment management firm that employs multiple absolute return strategies, utilizing rigorous fundamental analysis to identify growth opportunities that are uncorrelated to market indices.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Quantum Art | Apr 2026 | Series A Extension | Co-investor |
| Locus Fermentation Solutions | Dec 2025 | Convertible Debt | Lead |
| Locus Agricultural Solutions | Dec 2024 | Convertible Debt | Lead |
| Wuhan Asia Heart Hospital | Feb 2022 | Series D | Co-investor |
| GreenLight Biosciences Holdings, PBC | Feb 2022 | PIPE | Co-investor |
Key People
Alexander Berger
Managing Director
Brian Swerdloff
Managing Director, Portfolio Insights
Evan Sturza
Senior Managing Director -- Biotechnology Investments
Gabor Siklos
Managing Director, Risk Management
James Adams
Managing Director
John Pym
Managing Director
Nadine Kim
Managing Director
Randall Shy
Managing Director
Rick Allison
Managing Director Senior Counsel
Tom Sullivan
Managing Director
Tony Hokayem
Managing Director
Victor Simonte
Managing Director
Zachary Cion
Managing Director
George A.
Partner
Rebecca Benedict
Partner
Roy Astrachan
Partner
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
